SK82098A3 - Biologically active benzothiazolone ethanamines - Google Patents
Biologically active benzothiazolone ethanamines Download PDFInfo
- Publication number
- SK82098A3 SK82098A3 SK820-98A SK82098A SK82098A3 SK 82098 A3 SK82098 A3 SK 82098A3 SK 82098 A SK82098 A SK 82098A SK 82098 A3 SK82098 A3 SK 82098A3
- Authority
- SK
- Slovakia
- Prior art keywords
- compound
- formula
- pharmaceutically acceptable
- compounds
- acceptable salt
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/60—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings condensed with carbocyclic rings or ring systems
- C07D277/62—Benzothiazoles
- C07D277/68—Benzothiazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pulmonology (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Thiazole And Isothizaole Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB9526511.2A GB9526511D0 (en) | 1995-12-23 | 1995-12-23 | Pharmaceutically active compounds |
PCT/SE1996/001650 WO1997023470A1 (en) | 1995-12-23 | 1996-12-13 | Biologically active benzothiazolone ethanamines |
Publications (1)
Publication Number | Publication Date |
---|---|
SK82098A3 true SK82098A3 (en) | 1998-11-04 |
Family
ID=10786064
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SK820-98A SK82098A3 (en) | 1995-12-23 | 1996-12-13 | Biologically active benzothiazolone ethanamines |
Country Status (27)
Country | Link |
---|---|
US (1) | US5929100A (et) |
EP (1) | EP0918760B1 (et) |
JP (1) | JP2000502681A (et) |
KR (1) | KR19990076688A (et) |
CN (1) | CN1072214C (et) |
AR (1) | AR005008A1 (et) |
AT (1) | ATE209638T1 (et) |
AU (1) | AU704506B2 (et) |
BR (1) | BR9612234A (et) |
CA (1) | CA2238877A1 (et) |
CZ (1) | CZ288704B6 (et) |
DE (1) | DE69617472D1 (et) |
EE (1) | EE03440B1 (et) |
GB (1) | GB9526511D0 (et) |
HU (1) | HUP9900100A3 (et) |
IL (2) | IL142502A0 (et) |
IS (1) | IS4759A (et) |
MX (1) | MX9804828A (et) |
NO (1) | NO982927D0 (et) |
NZ (1) | NZ325500A (et) |
PL (1) | PL327475A1 (et) |
RU (1) | RU2177476C2 (et) |
SK (1) | SK82098A3 (et) |
TR (1) | TR199801196T2 (et) |
TW (1) | TW401411B (et) |
WO (1) | WO1997023470A1 (et) |
ZA (1) | ZA9610354B (et) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1999009018A1 (fr) * | 1997-08-14 | 1999-02-25 | Kirin Beer Kabushiki Kaisha | DERIVES DE BENZOTHIAZOLONE PRESENTANT UNE ACTIVITE SELECTIVE D'AGONISTE DU RECEPTEUR β2 |
AR040962A1 (es) * | 2002-08-09 | 2005-04-27 | Novartis Ag | Compuestos derivados de tiazol 1,3-2-ona, composicion farmaceutica y proceso de preparacion del compuesto |
GB0218629D0 (en) * | 2002-08-09 | 2002-09-18 | Novartis Ag | Organic compounds |
CA2543858C (en) | 2003-11-21 | 2014-04-15 | Theravance, Inc. | Compounds having beta2 adrenergic receptor agonist and muscarinic receptor antagonist activity |
TW200738658A (en) | 2005-08-09 | 2007-10-16 | Astrazeneca Ab | Novel compounds |
TW200738659A (en) * | 2005-08-29 | 2007-10-16 | Astrazeneca Ab | Novel compounds |
TW200745067A (en) | 2006-03-14 | 2007-12-16 | Astrazeneca Ab | Novel compounds |
TW200833670A (en) | 2006-12-20 | 2008-08-16 | Astrazeneca Ab | Novel compounds 569 |
GB0702458D0 (en) | 2007-02-08 | 2007-03-21 | Astrazeneca Ab | Salts 668 |
AU2009260899B2 (en) | 2008-06-18 | 2012-02-23 | Astrazeneca Ab | Benzoxazinone derivatives acting as beta2-adrenoreceptor agonist for the treatment of respiratory disorders |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4314944A (en) * | 1980-08-22 | 1982-02-09 | Smithkline Corporation | 4-Aminoalkyl-7-hydroxy-2(3H)-indolones |
US4452808A (en) * | 1982-12-07 | 1984-06-05 | Smithkline Beckman Corporation | 4-Aminoalkyl-2(3H)-indolones |
GB8426200D0 (en) * | 1984-10-17 | 1984-11-21 | Glaxo Holdings Ltd | Chemical compounds |
US4554284A (en) * | 1984-09-12 | 1985-11-19 | Smithkline Beckman Corporation | 7-(2-Aminoethyl)-1,3-benzthia- or oxa-zol-2(3H)-ones |
US4554287A (en) * | 1984-09-12 | 1985-11-19 | Smithkline Beckman Corporation | Antihypertensive 7-[2-(dialkylamino)ethyl]-4-hydroxy-1,3-benzimidazol-2-ones |
DK514585A (da) * | 1984-11-08 | 1986-05-09 | Syntex Inc | Aminoethylanilinderivater |
DE3728695A1 (de) * | 1987-08-25 | 1989-03-09 | Schering Ag | Neue benzimidazol-derivate |
IE914003A1 (en) * | 1990-11-20 | 1992-05-20 | Astra Pharma Prod | Biologically Active Amines |
GB9210632D0 (en) * | 1992-05-19 | 1992-07-01 | Fisons Plc | Compounds |
US5648370A (en) * | 1990-11-20 | 1997-07-15 | Astra Pharmaceuticals Limited | 7-(2-aminoethyl) benzothiazolones |
GB9211172D0 (en) * | 1992-05-27 | 1992-07-08 | Fisons Plc | Compounds |
-
1995
- 1995-12-23 GB GBGB9526511.2A patent/GB9526511D0/en active Pending
-
1996
- 1996-12-09 AR ARP960105568A patent/AR005008A1/es unknown
- 1996-12-09 ZA ZA9610354A patent/ZA9610354B/xx unknown
- 1996-12-11 TW TW085115316A patent/TW401411B/zh not_active IP Right Cessation
- 1996-12-13 RU RU98114080/04A patent/RU2177476C2/ru active
- 1996-12-13 SK SK820-98A patent/SK82098A3/sk unknown
- 1996-12-13 US US08/793,706 patent/US5929100A/en not_active Expired - Fee Related
- 1996-12-13 AU AU14025/97A patent/AU704506B2/en not_active Ceased
- 1996-12-13 EE EE9800193A patent/EE03440B1/et not_active IP Right Cessation
- 1996-12-13 CN CN96199237A patent/CN1072214C/zh not_active Expired - Fee Related
- 1996-12-13 EP EP96944153A patent/EP0918760B1/en not_active Expired - Lifetime
- 1996-12-13 CA CA002238877A patent/CA2238877A1/en not_active Abandoned
- 1996-12-13 IL IL14250296A patent/IL142502A0/xx unknown
- 1996-12-13 HU HU9900100A patent/HUP9900100A3/hu unknown
- 1996-12-13 DE DE69617472T patent/DE69617472D1/de not_active Expired - Lifetime
- 1996-12-13 JP JP09523560A patent/JP2000502681A/ja active Pending
- 1996-12-13 PL PL96327475A patent/PL327475A1/xx unknown
- 1996-12-13 KR KR1019980704800A patent/KR19990076688A/ko not_active Application Discontinuation
- 1996-12-13 NZ NZ325500A patent/NZ325500A/xx unknown
- 1996-12-13 TR TR1998/01196T patent/TR199801196T2/xx unknown
- 1996-12-13 WO PCT/SE1996/001650 patent/WO1997023470A1/en not_active Application Discontinuation
- 1996-12-13 AT AT96944153T patent/ATE209638T1/de not_active IP Right Cessation
- 1996-12-13 CZ CZ19981684A patent/CZ288704B6/cs not_active IP Right Cessation
- 1996-12-13 IL IL12499896A patent/IL124998A0/xx unknown
- 1996-12-13 BR BR9612234A patent/BR9612234A/pt not_active Application Discontinuation
-
1998
- 1998-05-27 IS IS4759A patent/IS4759A/is unknown
- 1998-06-16 MX MX9804828A patent/MX9804828A/es unknown
- 1998-06-23 NO NO982927A patent/NO982927D0/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
CA2238877A1 (en) | 1997-07-03 |
HUP9900100A2 (hu) | 1999-05-28 |
GB9526511D0 (en) | 1996-02-28 |
EE9800193A (et) | 1998-12-15 |
CN1211242A (zh) | 1999-03-17 |
HUP9900100A3 (en) | 2001-10-29 |
PL327475A1 (en) | 1998-12-07 |
NO982927L (no) | 1998-06-23 |
AU704506B2 (en) | 1999-04-22 |
CZ288704B6 (cs) | 2001-08-15 |
EP0918760A1 (en) | 1999-06-02 |
TW401411B (en) | 2000-08-11 |
IS4759A (is) | 1998-05-27 |
ZA9610354B (en) | 1997-06-23 |
EE03440B1 (et) | 2001-06-15 |
NZ325500A (en) | 1999-01-28 |
JP2000502681A (ja) | 2000-03-07 |
EP0918760B1 (en) | 2001-11-28 |
IL142502A0 (en) | 2002-03-10 |
IL124998A0 (en) | 1999-01-26 |
BR9612234A (pt) | 1999-07-13 |
TR199801196T2 (xx) | 1998-10-21 |
AU1402597A (en) | 1997-07-17 |
ATE209638T1 (de) | 2001-12-15 |
KR19990076688A (ko) | 1999-10-15 |
MX9804828A (es) | 1998-09-30 |
WO1997023470A1 (en) | 1997-07-03 |
AR005008A1 (es) | 1999-04-07 |
NO982927D0 (no) | 1998-06-23 |
CN1072214C (zh) | 2001-10-03 |
CZ168498A3 (cs) | 1998-09-16 |
US5929100A (en) | 1999-07-27 |
RU2177476C2 (ru) | 2001-12-27 |
DE69617472D1 (de) | 2002-01-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2006249866B2 (en) | Compositions and methods of treating retinal disease | |
RU2114108C1 (ru) | ПРОИЗВОДНЫЕ 7-(2-АМИНОЭТИЛ)БЕНЗОТИАЗОЛОНА ИЛИ ИХ ФАРМАЦЕВТИЧЕСКИ ПРИЕМЛЕМЫЕ СОЛИ, СПОСОБЫ ИХ ПОЛУЧЕНИЯ, ПРОИЗВОДНЫЕ N-[2-(4-ГИДРОКСИ-2-ОКСО-3H-1,3-БЕНЗОТИАЗОЛ-7-ИЛ)ЭТИЛАМИДА]ФАРМАЦЕВТИЧЕСКАЯ КОМПОЗИЦИЯ, ПРОЯВЛЯЮЩАЯ АГОНИСТИЧЕСКУЮ АКТИВНОСТЬ В ОТНОШЕНИИ β2-АДРЕНОРЕЦЕПТОРОВ | |
JP4896717B2 (ja) | N−メチル−置換ベンゾアミダゾール | |
SK82098A3 (en) | Biologically active benzothiazolone ethanamines | |
DE69607183T2 (de) | Benzothiazolone-derivate | |
WO1997023470A9 (en) | Biologically active benzothiazolone ethanamines | |
AU2008333929A1 (en) | Acid mimic compounds for the inhibition of isoprenyl-S-cysteinyl methyltransferase | |
US7399786B2 (en) | Derivatives of amino acids for treatment of obesity and related disorders | |
EP1496053B1 (en) | Kappa-opioid receptor agonist comprising a 2-phenylbenzothiazoline derivative | |
WO2018077898A1 (en) | N,n'-diarylurea, n,n'-diarylthiourea and n,n'-diarylguanidino compounds for use in treatment and prevention of inflammatory disease | |
US5036086A (en) | Novel benzothiazole derivatives | |
CN107304180B (zh) | 苯甲酰胺类衍生物、其制备方法及其在医药上的用途 | |
RU2172313C2 (ru) | Соединения бензотиазолона, способы и промежуточные соединения для их получения, а также содержащие их фармацевтические композиции | |
JPH03148263A (ja) | フェノキシプロピルアミン誘導体またはその塩ならびにこれらを含有する抗潰瘍剤 |